Fennec Pharmaceuticals Inc(FRX-T)TSX
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Fennec Pharmaceuticals Inc
68 TW Alexander DrivePO Box 13628
Research Triangle Park NC 27709 USA
P: 919-636-4530
https://www.fennecpharma.com
Profile
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Key Executives
| Name | Title |
|---|---|
| Pierre S. Sayad | Chief Medical Officer |
| Terry Evans | Other Executive Officer |
| Christiana Cioffi | Chief Strategy Officer |